交易 Praxis Precision Medicines Inc - PRAXus 差价合约
Praxis Precision Medicines Inc. (NASDAQ: PRAX) is a clinical-stage biopharmaceutical company developing therapies for central nervous system disorders such as epilepsy, movement disorders, and depression. Its approach uses genetic insights and neuroscience to target underlying brain-circuit dysfunctions. Praxis’s share performance is typically driven by trial readouts, regulatory progress, and investor sentiment toward innovative CNS drug development.最新股票文章

SpaceX上市首日收涨19%——IPO后如何交易SpaceX SPCX差价合约
SpaceX(SPCX)于2026年6月12日在纳斯达克首次上市,开盘报150美元,收盘报160.95美元,较135美元的IPO发行价上涨19.2%。
08:41, 16 六月 2026


